Pharma Exclusives Pressreleases
FDA Grants Priority Review to Merck’s Application for WELIREG® (belzutifan) for the Treatment of Patients With Advanced Pheochromocytoma and Paraganglioma (PPGL)
Monday, January 27, 2025Merck known as MSD outside of the United States and Canada today announced the US Food and Drug Administration FDA has accepted for priority review a supplemental new drug application sNDA seeking approval of WELIREG belzutifan Mercks oral hypoxiaind...
Lantern Pharma Unveils Innovative AI-Powered Module to Improve the Precision, Cost and Timelines of Antibody-Drug Conjugate (ADC) Development for Cancer
Monday, January 27, 2025Lantern Pharma Incan artificial intelligence AI company dedicated to developing cancer therapies and transforming the cost pace and timeline of oncology drug discovery and development today announced advancements in the application of its RADR AI pla...
AstraZeneca plans C$820 million (US$570m) investment in Canada to advance growing global hub and clinical delivery
Friday, January 24, 2025AstraZeneca a global pharmaceutical company focused on developing life changing medicines today announced a C million USm investment in Canada creating more than highskilled jobs across all areas of the business
AbbVie and Neomorph Announce Collaboration to Develop Molecular Glue Degraders for Oncology and Immunology
Friday, January 24, 2025AbbVieand Neomorph Inc today announced a collaboration and optiontolicense agreement to develop novel molecular glue degraders for multiple targets across oncology and immunology
Moderna Awarded Tender for the Supply of Its mRNA COVID-19 Vaccine in the European Union
Friday, January 24, 2025Moderna Inctoday announced that it has been awarded a tender for the supply of its mRNA COVID vaccine in the European Union EU Norway and North Macedonia Under the resulting agreement participating countries can access Modernas mRNA COVID vaccine fo...
BD and Biosero Collaborate to Enable Robotic Integration with Flow Cytometers Used in Drug Discovery and Development
Thursday, January 23, 2025BD a leading global medical technology company and Biosero a developer of laboratory automation solutions to orchestrate scientific discoveries today announced a framework collaboration agreement to enable and facilitate robotic arm integration
Shuttle Pharma Reaches Milestone in Patient Enrollment for Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma
Wednesday, January 22, 2025Shuttle Pharmaceuticals Holdings Inc a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer patients treated with radiation therapy RT announced today that it has achieved enrollment in the initia...
Coya Therapeutics Announces Pipeline Expansion - COYA 303: COYA 301 in Combination with GLP-1 Receptor Agonist for the Treatment of Inflammatory Diseases
Wednesday, January 22, 2025Coya Therapeutics Inc a clinicalstage biotechnology company developing biologics intended to enhance regulatory T cell Treg function announces the expansion of its investigational pipeline and advancement of COYA for the treatment of inflammatory di...
Cybin Launches Strategic Clinical Site Partnerships to Support PARADIGM, a Multinational Pivotal Phase 3 Program Evaluating CYB003 for the Adjunctive Treatment of Major Depressive Disorder
Thursday, January 16, 2025Cybin Inc a clinicalstage breakthrough neuropsychiatry platform company committed to revolutionizing mental healthcare by developing new and innovative nextgeneration treatment options today announced the launch of its first strategic partnership agr...
Kindeva Drug Delivery and Emervax Partner To Bring Game Changing Vaccine Administration to Patients
Friday, January 10, 2025Kindeva Drug Delivery a global CDMO and drug delivery expert and Emervax a developer of a proprietary circular RNAbased vaccine platform emxRNATM today announced an exclusive partnership to codevelop a gamechanging solution for the administration of...
